Modelling the cost-effectiveness of catch-up ‘MenB’ (Bexsero) vaccination in England

We assessed the cost-effectiveness of offering catch-up vaccination with Bexsero against meningococcal disease to children too old to receive the vaccine under the recently introduced infant programme. Offering catch-up vaccination to increasingly older children is less economically attractive becau...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Hannah, Trotter, Caroline L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2017
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418563/
https://www.ncbi.nlm.nih.gov/pubmed/27923519
http://dx.doi.org/10.1016/j.vaccine.2016.11.076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418563/
https://www.ncbi.nlm.nih.gov/pubmed/27923519
http://dx.doi.org/10.1016/j.vaccine.2016.11.076

Ejemplares similares